Streetbeat News

Regulatory

BNSO

Bonso Electronics plans to voluntarily delist its common stock from Nasdaq and deregister its common stock under the Securities Exchange Act of 1934, suspending its public reporting obligations.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 10:04 am

SPY

VGK

The U.S. is expected to approve the supply of depleted-uranium tank rounds to Ukraine, according to the Wall Street Journal. This move could potentially impact the SPY and VGK ETFs.

Portfolio Pulse from Charles Gross

June 13, 2023 | 9:51 am

IMTX

Immatics Biotechnologies has been granted U.S. Patent #11673917 for peptides, combination of peptides, and cell-based medicaments for use in immunotherapy against urinary bladder cancer and other cancers.

Portfolio Pulse from Charles Gross

June 13, 2023 | 9:39 am

PSO

Pearson Education has been granted U.S. Patent #11676048 for systems and methods for validation of artificial intelligence models. The patent will help improve the quality and reliability of AI models in the education sector.

Portfolio Pulse from Charles Gross

June 13, 2023 | 9:32 am

TSLA

Tesla has been granted U.S. Patent #11675358 for its autonomous driving system emergency signaling. This patent will enhance the safety features of Tesla's self-driving vehicles.

Portfolio Pulse from Charles Gross

June 13, 2023 | 9:22 am

SPY

VGK

Belarusian President Lukashenko stated that the deployment of Russian tactical nuclear weapons in Belarus serves as a deterrent to discourage potential aggressors, according to Reuters citing Belta.

Portfolio Pulse from Charles Gross

June 13, 2023 | 9:11 am

SPY

VGK

Belarusian President Lukashenko stated that Belarus would not hesitate to use nuclear weapons if faced with aggression, according to Reuters citing Belta.

Portfolio Pulse from Charles Gross

June 13, 2023 | 9:08 am

AZN

AstraZeneca's Soliris (Eculizumab) has received approval in China for the treatment of adult patients with refractory generalized myasthenia gravis who are anti-acetylcholine receptor antibody-positive.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 8:14 am

VALN

Valneva has published Phase 3 data for its single-shot Chikungunya vaccine candidate, VLA1553, in The Lancet. The vaccine demonstrated a 98.9% seroresponse rate, with 96% of participants maintaining seroresponse six months after vaccination.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 8:10 am

SHIBUSD

A mysterious whale has accumulated 1.5 trillion Shiba Inu (CRYPTO: SHIB) tokens worth $10 million from Binance and Coinbase, making them the largest holder of SHIB, excluding exchanges. This comes amid the SEC's legal battle against crypto exchanges and a 21.4% decline in SHIB's value over the past week.

Portfolio Pulse from Mehab Qureshi

June 13, 2023 | 6:56 am